Filgrastim Neupogen, Neulasta

Filgrastim Neupogen, Neulasta

This chemotherapy and cancer drugs article is about Filgrastim (Neupogen, Neulasta) which is used to treat neutropenia (a low number of white blood cells or neutrophils) often caused by chemotherapy. Known as a haemopoietic growth factor, it stimulates the bone marrow to increase white cell production, thus reducing neutropenia which can lead to infections and neutropenic scepsis which is very serious.   Use of Filgrastim means that chemotherapy can be given in a more intense schedule.  It is usually administered by injection or sometimes intravenously.

Side effects can include: (Yes, there are side-effects of the drug that is used to reduce side effects!) but they are unusual. They include the possibility of enlarged spleen and shortness of breath. Anyone with osteoporosis should have regular checks for bone density if taking this drug for long periods.  

Approved by

the Medical Board. 

Click Here

 

 

 

 

 

 

Other articles that you may find interesting are:

  1. A diet for Chemotherapy
  2. Immunotherapy overview
  3. A to Z Guide to Complementary Therapies

Go to: Return to the CANCERactive drug list

 

Learn about your cancer drugs.
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our
Newsletter

Join Our Newsletter Signup today for free and be the first to get notified on new updates.